266 related articles for article (PubMed ID: 8215738)
1. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
McClean E; Graham CA; Ward AJ; Young IS; Martin S; Nicholls DP
Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
[TBL] [Abstract][Full Text] [Related]
4. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
5. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
6. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
7. Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and Canada.
Defesche JC; van de Ree MA; Kastelein JJ; van Diermen DE; Janssens NW; van Doormaal JJ; Hayden MR
Clin Genet; 1992 Dec; 42(6):273-80. PubMed ID: 1493640
[TBL] [Abstract][Full Text] [Related]
8. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
9. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
Tybjaerg-Hansen A; Steffensen R; Meinertz H; Schnohr P; Nordestgaard BG
N Engl J Med; 1998 May; 338(22):1577-84. PubMed ID: 9603795
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of coronary heart disease in familial hypercholesterolemia].
Miserez AR; Keller U
Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
[TBL] [Abstract][Full Text] [Related]
11. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
Khoo KL; Van Acker P; Tan H; Deslypere JP
Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
[TBL] [Abstract][Full Text] [Related]
13. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
14. [Screening for mutations in apolipoprotein B genes in a group of patients with hyperlipoproteinemia].
Grombiríková H; Freiberger T; Kuhrová V; Soska V; Nedomová K
Cas Lek Cesk; 2001 Jan; 140(1):18-21. PubMed ID: 11242979
[TBL] [Abstract][Full Text] [Related]
15. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
16. Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100.
Tybjaerg-Hansen A
Scand J Clin Lab Invest Suppl; 1995; 220():57-76. PubMed ID: 7652481
[TBL] [Abstract][Full Text] [Related]
17. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
18. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
[TBL] [Abstract][Full Text] [Related]
19. [Familial hypercholesterolemia].
Turpin G; Bruckert E
Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642
[TBL] [Abstract][Full Text] [Related]
20. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease.
Tybjaerg-Hansen A; Humphries SE
Atherosclerosis; 1992 Oct; 96(2-3):91-107. PubMed ID: 1466657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
